Physician profile
Sumana Reddy
NPI 1053300251
$694.38
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $287 · 2021: $18.47 · 2022: $17.50 · 2023: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $147.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Portola Pharmaceuticals, LLC | $126.35 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $124.30 | 2019-2023 | Tezspire |
| Leo Pharma INC. | $101.56 | 2023 | Adbry |
| Genentech USA, INC. | $91.32 | 2020 | |
| Optinose US, INC. | $68.63 | 2019 | |
| Alk-Abello, INC | $63.41 | 2019-2020 | |
| Redhill Biopharma INC. | $33.63 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $19.26 | 2023 | Dupixent |
| Qol Medical, LLC | $18.47 | 2021 | |
| Phadia US INC. | $17.99 | 2019 | |
| Pfizer INC. | $16.02 | 2019 | |
| Kaleo, INC. | $13.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumana Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.